All-trans retinoic acid enhances the transport of phase II metabolites of benzo[a]pyrene by inducing the Breast Cancer Resistance Protein expression in Caco-2 cells

Toxicology Letters

Volumn 197, Issue 2, 2010, Pages 151-155

  Hessel, Stefanie ^a   Lampen, Alfonso ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

All trans retinoic acid; BCRP; Benzo a pyrene

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; BENZO[A]PYRENE; BENZO[A]PYRENE 3 SULFATE; BEXAROTENE; BREAST CANCER RESISTANCE PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DETOXIFICATION; EXCRETION; FOOD CONTAMINATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; INTESTINE CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; XENOBIOTIC METABOLISM;

ATP-BINDING CASSETTE TRANSPORTERS; BENZO(A)PYRENE; BENZOATES; CACO-2 CELLS; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; SIGNAL TRANSDUCTION; TETRAHYDRONAPHTHALENES; TRETINOIN;

ATRA;

EID: 77953959069     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.05.018     Document Type: Article

References (33)

1. Arnhold T., Nau H., Meyer S., Rothkoetter H.J., Lampen A.D. Porcine intestinal metabolism of excess vitamin a differs following vitamin a supplementation and liver consumption. J. Nutr. 2002, 132:197-203.
2. Baltes S., Nau H., Lampen A. All-trans retinoic acid enhances differentiation and influences permeability of intestinal Caco-2 cells under serum-free conditions. Dev. Growth Differ. 2004, 46:503-514.
3. Boulenc X., Bourrie M., Fabre I., Roque C., Joyeux H., Berger Y., Fabre G. Regulation of cytochrome P450IA1 gene expression in a human intestinal cell line, Caco-2. J. Pharmacol. Exp. Ther. 1992, 263:1471-1478.
4. Buening M.K., Wislocki P.G., Levin W., Yagi H., Thakker D.R., Akagi H., Koreeda M., Jerina D.M., Conney A.H. Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Proc. Natl. Acad. Sci. U.S.A. 1978, 75:5358-5361.
5. Buesen R., Mock M., Seidel A., Jacob J., Lampen A. Interaction between metabolism and transport of benzo[a]pyrene and its metabolites in enterocytes. Toxicol. Appl. Pharmacol. 2002, 183:168-178.
6. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996, 10:940-954.
7. Ebert B., Seidel A., Lampen A. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 2005, 26:1754-1763.
8. Ebert B., Seidel A., Lampen A. Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of benzo[a]pyrene-3-sulfate. Toxicol. Sci. 2007, 96:227-236.
9. Ee P.L., Kamalakaran S., Tonetti D., He X., Ross D.D., Beck W.T. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res. 2004, 64:1247-1251.
10. Evseenko D.A., Paxton J.W., Keelan J.A. The xenobiotic transporter ABCG2 plays a novel role in differentiation of trophoblast-like BeWo cells. Placenta 2007, 28(Suppl. A):S116-S120.
11. Gudas L.J. Retinoids and vertebrate development. J. Biol. Chem. 1994, 269:15399-15402.
12. Heyman R.A., Mangelsdorf D.J., Dyck J.A., Stein R.B., Eichele G., Evans R.M., Thaller C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992, 68:397-406.
13. Hirai T., Fukui Y., Motojima K. PPARalpha agonists positively and negatively regulate the expression of several nutrient/drug transporters in mouse small intestine. Biol. Pharm. Bull. 2007, 30:2185-2190.
14. Imai Y., Ishikawa E., Asada S., Sugimoto Y. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. Cancer Res. 2005, 65:596-604.
15. Koreeda M., Moore P.D., Wislocki P.G., Levin W., Yagi H., Jerina D.M. Binding of benzo[a]pyrene 7,8-diol-9,10-epoxides to DNA, RNA, and protein of mouse skin occurs with high stereoselectivity. Science 1978, 199:778-781.
16. Lampen A., Meyer S., Arnhold T., Nau H. Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytes. J. Pharmacol. Exp. Ther. 2000, 295:979-985.
17. Lampen A., Meyer S., Nau H. Effects of receptor-selective retinoids on CYP26 gene expression and metabolism of all-trans-retinoic acid in intestinal cells. Drug Metab. Dispos. 2001, 29:742-747.
18. Levin A.A., Sturzenbecker L.J., Kazmer S., Bosakowski T., Huselton C., Allenby G., Speck J., Kratzeisen C., Rosenberger M., Lovey A. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature 1992, 355:359-361.
19. Lippman S.M., Lotan R. Advances in the development of retinoids as chemopreventive agents. J. Nutr. 2000, 130:479.
20. Maden M. The role of retinoic acid in embryonic and post-embryonic development. Proc. Nutr. Soc. 2000, 59:65-73.
21. Meinl W., Ebert B., Glatt H., Lampen A. Sulfotransferase forms expressed in human intestinal Caco-2 and TC7 cells at varying stages of differentiation and role in benzo[a]pyrene metabolism. Drug Metab. Dispos. 2008, 36:276-283.
22. Meyer zu Schwabedissen H.E., Grube M., Dreisbach A., Jedlitschky G., Meissner K., Linnemann K., Fusch C., Ritter C.A., Volker U., Kroemer H.K. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metab. Dispos. 2006, 34:524-533.
23. Munzel P.A., Schmohl S., Heel H., Kalberer K., Bock-Hennig B.S., Bock K.W. Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells. Drug Metab. Dispos. 1999, 27:569-573.
24. Peters W.H., Roelofs H.M., Nagengast F.M., van Tongeren J.H. Human intestinal glutathione S-transferases. Biochem. J. 1989, 257:471-476.
25. Scharmach E., Hessel S., Niemann B., Lampen A. Glutathione S-transferase expression and isoenzyme composition during cell differentiation of Caco-2 cells. Toxicology 2009, 265:122-126.
26. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 1985, 150:76-85.
27. Szatmari I., Vamosi G., Brazda P., Balint B.L., Benko S., Szeles L., Jeney V., Ozvegy-Laczka C., Szanto A., Barta E., Balla J., Sarkadi B., Nagy L. Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J. Biol. Chem. 2006, 281:23812-23823.
28. Tamura H.O., Taniguchi K., Hayashi E., Hiyoshi Y., Nagai F. Expression profiling of sulfotransferases in human cell lines derived from extra-hepatic tissues. Biol. Pharm. Bull. 2001, 24:1258-1262.
29. Thakker D.R., Yagi H., Lu A.Y., Levin W., Conney A.H. Metabolism of benzo[a]pyrene: conversion of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to highly mutagenic 7,8-diol-9,10-epoxides. Proc. Natl. Acad. Sci. U.S.A. 1976, 73:3381-3385.
30. Wang H., Zhou L., Gupta A., Vethanayagam R.R., Zhang Y., Unadkat J.D., Mao Q. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E798-E807.
31. Yasuda S., Itagaki S., Hirano T., Iseki K. Effects of sex hormones on regulation of ABCG2 expression in the placental cell line BeWo. J. Pharm. Pharm. Sci. 2006, 9:133-139.
32. Yasuda S., Kobayashi M., Itagaki S., Hirano T., Iseki K. Response of the ABCG2 promoter in T47D cells and BeWo cells to sex hormone treatment. Mol. Biol. Rep. 2009, 36:1889-1896.
33. Yeboah D., Sun M., Kingdom J., Baczyk D., Lye S.J., Matthews S.G., Gibb W. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can. J. Physiol. Pharmacol. 2006, 84:1251-1258.